Registration is now closed

 

Event Details

  • Date: Thursday, April 10, starting at 5:30 pm
  • Location: Marsh McLennan, 1166 6th Ave, New York, NY 10036
  • Format: Happy hour reception with a panel presentation and live Q&A
  • Audience: Exclusively for benefit plan sponsors

This event is exclusively tailored for benefit plan sponsors and seating is limited. We reserve the right to ensure that all attendees align with our event's purpose.

 

 

Agenda

 

5:30 pm: Reception and happy hour

6:15 pm: Panel presentation

7:00 pm: Live Q&A

7:15 pm: Closing remarks

 

 

Meet Our Panelists

 

Kevin Hern

Sr. Vice President,

Lilly USA LLC

 

Eric Levin 

Co-founder and CEO

Scripta Insights

 

Cora Opsahl 

Director

32BJ Benefit Funds

 

Karen Springstead 

National Pharmacy Practice Leader

Marsh McLennan Agency

 

Hannan Allen 

Managing Director, Pharmacy Consulting

Marsh McLennan Agency

 

 

 

Event Description

 

Join us for an insightful evening designed specifically for benefit plan sponsors where we will address the critical challenges payors face in managing pharmacy benefits. As the pharmacy benefit landscape evolves at a rapid pace, plan sponsors are increasingly confronted with rising drug costs and limited options, straining budgets and impacting overall healthcare expenditures.

 

Our event aims to propel the industry forward by tackling the growing litigation and regulatory changes reshaping the landscape, as well as the pressing need for enhanced transparency and competition. With new Pharmacy Benefit Managers (PBMs) and alternative payor options emerging in the market, understanding their implications for your bottom line and improving medication access for patients is becoming increasingly more crucial.

 

This event presents a unique opportunity to engage with industry experts and peers as we explore innovative solutions to optimize pharmacy benefits in today’s complex environment.

 

 

Key Benefits of Attending

  • Informed Decisions: discuss the real impact and effectiveness of the current Pharmacy Benefit Manager (PBM) models on containing drug costs.
  • Market Alternatives: explore emerging pharmacy benefit alternatives.
  • Regulatory Awareness: understand the impact of the latest legislative proposals and pending lawsuits that may alter your pharmacy strategies.
  • Fiduciary Responsibilities: understand your obligations as an employer and steps to take to better protect your organization.
  • Risk Management Strategies: Explore non-traditional approaches and the relationship between true drug transparency and costs that may affect your bottom line.

Join your peers and industry leaders for this insightful event and take the first step towards transforming your pharmacy benefit approach. We look forward to guiding you in navigating the evolving landscape ahead.

 

 

Presented by